Oral Solid Dose CDMOs

Genuone Sciences Inc. is a South Korean pharmaceutical CDMO valued at approximately $752 million, offering specialized contract development and manufacturing services including formulation development through finished product production. The company provides pharmaceutical manufacturing and analytical services for both domestic and international clients. Genuone is 100% owned by IMM Private Equity.

Glatt Pharmaceutical Services is a CDMO division of the Glatt Group that supports pharmaceutical and biotech companies from initial formulation design to commercial-scale manufacturing. The company specializes in oral solid dosage forms using advanced technologies including fluidized bed systems, spray granulation, Wurster coating, hot-melt extrusion, and amorphous solid dispersions for solubility enhancement and modified release.

Lachifarma is an Italian CMO/CDMO based in Zollino (Lecce), Italy, offering research, technological development, and pharmaceutical contract manufacturing services. Listed as an EU GMP CMO, it appears in European CDMO landscape analyses alongside companies like Fine Foods, Doppel, and Biofarma. Lachifarma has been involved in vaccine-related contract manufacturing and offers pharmaceutical dose manufacturing services.

Lyomark Pharma GmbH

Germany

Lyomark Pharma GmbH is a German CDMO specializing in sterile medicinal products. They organize contract manufacturing based on dossiers they compile and maintain, and offer regulatory services. Through their subsidiary Lyocontract, they operate a state-of-the-art pharmaceutical manufacturing site. They have 39 FDA-approved products across injectable, oral solid, and liquid dosage forms. The company focuses on niche indications for the hospital market with global distribution.

Morgen Pharmaceutical Services (MPhS), operating as Stason Pharmaceuticals, is a US-based CDMO offering end-to-end drug development and manufacturing services. Located in Irvine, California, the facility can produce over 2 billion oral doses per year with batch sizes from 0.5 kg to 600 kg. The company offers API synthesis (through offshore affiliates), formulation development, pre-formulation studies, solid dosage manufacturing (tablets and capsules), high-containment operations for highly potent compounds (OEL < 1 µg/m³), and injectable/liquid manufacturing through a partner facility in Tainan, Taiwan. FDA-registered with 2 FEI numbers and 11 FDA inspections (8 NAI, 3 VAI).

Indian pharmaceutical CDMO specializing in pre-finished formulation intermediates (PFI) and finished dosage forms (FDF). Manufactures oral solids, oral liquids, injectables, ophthalmics, topicals, and inhalation products. Strong focus on pellet technology and nanotechnology-based drug delivery systems. CRAMS (Contract Research and Manufacturing Services) provider.

Nanjing Sino Pharmaceutical Ltd.

China

Chinese pharmaceutical company specializing in production, R&D, and export of generic medicines globally. Covers 1,000+ products across antibiotic, antimalarial, analgesic-antipyretic, cardiovascular, respiratory, antiviral/anti-cancer, hormone, and other therapeutic categories. 20+ years of international registration and export experience in dozens of countries. FDA registered with 3 FEI numbers.

NEON LABORATORIES LTD

India

Indian pharmaceutical company (established 1984) that emerged as a leader in anesthesia and critical care products. Manufactures 500+ products sold in 70+ markets. Multi-located manufacturing facilities including API and formulations. Started as contract manufacturer for anesthesia products (1992) and grew into branded generics. Major plant at Palghar with 460 million units capacity. Has dedicated manufacturing units for cephalosporins and oncology to avoid cross-contamination. 2000+ employees. FDA registered with 3 FEI numbers, 29 inspections (13 NAI, 15 VAI, 1 OAI). Began API production in 2008. Also has medical devices division (HOSPRO).

Elysium Pharmaceuticals Ltd. is an Indian pharmaceutical company based in Vadodara, Gujarat, with FDA-registered manufacturing facilities (1 FEI, 3 inspections including 1 NAI and 2 VAI). Limited public information is available due to website being down, but FDA registration and LinkedIn profiles confirm pharmaceutical manufacturing operations. Evidence of contract manufacturing is limited.

Eubioco is a Polish contract development and manufacturing organization (CDMO) offering contract manufacturing of medicines, supplements, and veterinary products. The company has an office and production complex in Dywity and employs more than 150 people, with capabilities spanning pharmaceutical and nutraceutical liquid and semi-solid forms.

FRIKE Pharma AG is a Swiss pharmaceutical contract manufacturer (CMO) providing GMP-compliant contract manufacturing, filling, and packaging services for pharmaceutical products. The company specializes in liquid, semi-solid, and solid dosage forms including pump sprays, suppositories, lotions, ointments, and tinctures.

Lucent Biotech Limited

India

Lucent Biotech Limited is an Indian third-party pharmaceutical manufacturer founded in 2006 in Roorkee (Haridwar). They manufacture a wide spectrum of pharmaceutical formulations and serve as suppliers for multiple Indian and multinational pharmaceutical companies. They are a contract manufacturer (third-party manufacturer) of pharmaceutical finished dosage forms.